Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04101331
Title Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides (REDIRECT)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Affimed GmbH
Indications

peripheral T-cell lymphoma

mycosis fungoides

Therapies

AFM13

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.